Diagnostic Value of CD138 and GATA3 in Benign Prostatic Hyperplasia and Prostate Cancer

Scientists evaluated the diagnostic utility of GATA3 and CD138 as basal compartment markers in differentiating benign prostatic hyperplasia from prostate cancer.